Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Capricor
Capricor
Duchenne muscular dystrophy: major trials and events to watch in 2023
Clinical Trials Arena
Thu, 03/16/23 - 09:49 am
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
Sarepta Therapeutics
SRP-9001
FibroGen
pamrevlumab
Capricor
CAP-1002
Santhera
ReveraGen
vamorolone
Capricor's DMD clinical trial meets primary endpoints
Endpoints
Fri, 09/24/21 - 11:52 am
Capricor
clinical trials
Duchenne Muscular Dystrophy
CAP-1002
One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
Endpoints
Wed, 05/13/20 - 11:28 am
Capricor
stem cells
Duchenne Muscular Dystrophy
CAP-1002
J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it
Endpoints
Fri, 07/7/17 - 02:38 pm
JNJ
Capricor
stem cells
Linda Marban
Capricor: Can A Scarred Heart Be Repaired?
Seeking Alpha
Mon, 01/13/14 - 08:42 am
heart attacks
devices
CAP-1002
Capricor
J&J gambles $12.5M in rare Big Pharma bet on a stem cell therapy
Fierce Biotech
Mon, 01/6/14 - 09:49 am
JNJ
stem cells
Capricor
Capricor gets $12.5M upfront payment in Janssen development agreement
Yahoo/Fly on the Wall
Sat, 01/4/14 - 04:16 pm
Capricor
Janssen
CAP-1002